Total Payments
$30,426
2024 Payments
$3,385
Companies
72
Transactions
1,136
Medicare Patients
4,455
Medicare Billing
$429,241
Payment Breakdown by Category
Food & Beverage$29,124 (95.7%)
Education$801.94 (2.6%)
Consulting$500.00 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $29,124 | 1,117 | 95.7% |
| Education | $801.94 | 18 | 2.6% |
| Consulting Fee | $500.00 | 1 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $3,306 | 86 | $0 (2024) |
| Novo Nordisk Inc | $2,818 | 99 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,145 | 68 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,113 | 47 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $1,517 | 32 | $0 (2023) |
| Lilly USA, LLC | $1,515 | 73 | $0 (2024) |
| ABBVIE INC. | $1,376 | 67 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,319 | 52 | $0 (2024) |
| Amarin Pharma Inc. | $1,194 | 38 | $0 (2021) |
| PFIZER INC. | $1,122 | 65 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,385 | 119 | Amgen Inc. ($434.93) |
| 2023 | $2,576 | 75 | Kowa Pharmaceuticals America, Inc. ($522.67) |
| 2022 | $3,861 | 142 | Novo Nordisk Inc ($485.23) |
| 2021 | $4,284 | 182 | Novo Nordisk Inc ($637.01) |
| 2020 | $2,458 | 122 | AstraZeneca Pharmaceuticals LP ($322.80) |
| 2019 | $3,693 | 118 | AstraZeneca Pharmaceuticals LP ($453.19) |
| 2018 | $4,533 | 170 | Amgen Inc. ($778.90) |
| 2017 | $5,636 | 208 | Pylant Medical ($600.00) |
All Payment Transactions
1,136 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Gastroenterology | ||||||
| 12/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: UROLOGY | ||||||
| 12/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Automated insulin delivery system | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: Bone Health | ||||||
| 11/25/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.35 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.38 | General |
| Category: DIABETES | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/19/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $4.49 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $118.67 | General |
| Category: Bone Health | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Gastroenterology | ||||||
| 11/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Cardio-renal | ||||||
| 11/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $118.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.97 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Gastroenterology | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: DIABETES | ||||||
| 10/28/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $8.63 | General |
| Category: Bone Health | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Respiratory | ||||||
| 10/21/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.25 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $100.05 | General |
| Category: CELLT | ||||||
| 10/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 929 | 1,554 | $292,239 | $88,962 |
| 2022 | 16 | 1,006 | 1,728 | $326,373 | $100,211 |
| 2021 | 21 | 1,307 | 2,172 | $404,274 | $128,919 |
| 2020 | 15 | 1,213 | 2,152 | $355,597 | $111,150 |
Total Patients
4,455
Total Services
7,606
Medicare Billing
$429,241
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 236 | 426 | $96,356 | $23,313 | 24.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 157 | 157 | $53,251 | $20,405 | 38.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 137 | 221 | $62,237 | $19,167 | 30.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 34 | 191 | $19,780 | $7,548 | 38.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 22 | 24 | $16,676 | $5,152 | 30.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 37 | 54 | $9,612 | $3,488 | 36.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 14 | 15 | $7,443 | $2,382 | 32.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 121 | 121 | $5,519 | $2,253 | 40.8% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 23 | 34 | $8,396 | $2,245 | 26.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 53 | 169 | $7,848 | $1,536 | 19.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 16 | $2,253 | $700.61 | 31.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 19 | 30 | $1,686 | $542.30 | 32.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 16 | 16 | $574.00 | $115.70 | 20.2% |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | Office | 2023 | 33 | 45 | $497.49 | $111.09 | 22.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 12 | 35 | $111.50 | $2.65 | 2.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 256 | 501 | $111,225 | $29,611 | 26.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 172 | 264 | $77,289 | $22,527 | 29.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 158 | 158 | $51,553 | $20,818 | 40.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 37 | 232 | $22,238 | $7,068 | 31.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 25 | 30 | $20,707 | $6,592 | 31.8% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 32 | 39 | $9,602 | $3,070 | 32.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 39 | 48 | $8,549 | $2,737 | 32.0% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 12 | 13 | $6,582 | $2,160 | 32.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 114 | 114 | $5,358 | $2,122 | 39.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 48 | 186 | $6,897 | $1,596 | 23.1% |
About Dr. Gregory Phillips, MD
Dr. Gregory Phillips, MD is a Internal Medicine healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699705152.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Phillips, MD has received a total of $30,426 in payments from pharmaceutical and medical device companies, with $3,385 received in 2024. These payments were reported across 1,136 transactions from 72 companies. The most common payment nature is "Food and Beverage" ($29,124).
As a Medicare-enrolled provider, Phillips has provided services to 4,455 Medicare beneficiaries, totaling 7,606 services with total Medicare billing of $429,241. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Fort Worth, TX
- Active Since 07/03/2006
- Last Updated 01/09/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1699705152
Products in Payments
- FARXIGA (Drug) $1,620
- JARDIANCE (Drug) $1,600
- Repatha (Biological) $1,496
- Vascepa (Drug) $1,194
- Ozempic (Drug) $1,073
- ELIQUIS (Drug) $897.98
- TRELEGY ELLIPTA (Drug) $890.48
- Livalo (Drug) $876.42
- VRAYLAR (Drug) $856.52
- EVENITY (Biological) $738.04
- TRULICITY (Drug) $702.62
- Prolia (Biological) $623.77
- SHINGRIX (Biological) $559.90
- Victoza (Drug) $505.33
- XIFAXAN (Drug) $500.82
- RYBELSUS (Drug) $406.16
- INVOKANA (Drug) $389.63
- UBRELVY (Drug) $383.79
- Kerendia (Drug) $365.64
- Wegovy (Drug) $340.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fort Worth
Dr. Saravanan Balamuthusamy, M.d, M.D
Internal Medicine — Payments: $449,579
Internal Medicine $449,579
Stevan Gonzalez, Md, MD
Internal Medicine — Payments: $366,565
Internal Medicine $366,565
Tasneem Ahmed, D.o, D.O
Internal Medicine — Payments: $229,979
Internal Medicine $229,979
Dr. Sanjay Oommen, Md, MD
Internal Medicine — Payments: $56,958
Internal Medicine $56,958
Laura Armas-Kolostroubis, Md, MD
Internal Medicine — Payments: $48,384
Internal Medicine $48,384
Dr. Robert Keller, Md, MD
Internal Medicine — Payments: $46,706
Internal Medicine $46,706